Your browser doesn't support javascript.
loading
Effectiveness of Continued Ranibizumab Therapy in Neovascular Age-Related Macular Degeneration versus Switch to Aflibercept: Real World Evidence.
Chakravarthy, Usha; Bezlyak, Vladimir; Sagkriotis, Alexandros; Griner, Ray; Skelly, Adrian; Boyer, David S; Milnes, Fran.
Affiliation
  • Chakravarthy U; Department of Ophthalmology, Queen's University of Belfast, Royal Victoria Hospital, Belfast, United Kingdom. Electronic address: u.chakravarthy@qub.ac.uk.
  • Bezlyak V; Novartis Pharma AG, Basel, Switzerland.
  • Sagkriotis A; Novartis Pharma AG, Basel, Switzerland.
  • Griner R; IQVIA, Cambridge, Massachusetts.
  • Skelly A; Novartis Pharma AG, Basel, Switzerland.
  • Boyer DS; Retina-Vitreous Associates Medical Group, Beverly Hills, California.
  • Milnes F; Novartis Pharma AG, Basel, Switzerland.
Ophthalmol Retina ; 3(1): 8-15.e1, 2019 01.
Article in En | MEDLINE | ID: mdl-30929819
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Visual Acuity / Receptors, Vascular Endothelial Growth Factor / Wet Macular Degeneration / Ranibizumab Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Ophthalmol Retina Year: 2019 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Visual Acuity / Receptors, Vascular Endothelial Growth Factor / Wet Macular Degeneration / Ranibizumab Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Ophthalmol Retina Year: 2019 Document type: Article Country of publication: Estados Unidos